Glaucoma is treatable, but it cannot be cured. The damage it causes to the optic nerve is permanent, so the goal of every treatment is to stop further vision loss rather than restore what’s already gone. This makes early detection critical: the sooner treatment begins, the more vision you keep.
Roughly 7 out of 10 glaucoma cases in developed countries remain undiagnosed, according to a meta-analysis published by the American Academy of Ophthalmology. In lower-income countries, that number climbs above 90%. Because glaucoma progresses silently in most forms, many people don’t realize anything is wrong until significant vision has been lost.
How Eye Drops Lower Eye Pressure
Most people with glaucoma start treatment with prescription eye drops. These work by either reducing the amount of fluid your eye produces or helping it drain more efficiently. The two most common first-line classes take different approaches: one type increases fluid drainage through a secondary outflow route, while the other slows fluid production inside the eye. Both are typically applied once or twice daily.
A newer class of drops works differently from all previous options. Instead of targeting fluid production or the secondary drainage pathway, it relaxes the tissue in the eye’s primary drainage channel (the trabecular meshwork), making it easier for fluid to flow out. It also reduces fluid production and lowers pressure in the tiny veins that carry fluid away from the eye. This triple mechanism is unique among glaucoma medications, and a combination formulation pairing it with an older drop class has shown statistically significant pressure reductions beyond what either achieves alone.
Sticking with your drops matters. Skipping doses leads to uncontrolled eye pressure, which accelerates vision loss. This sounds obvious, but adherence is one of the biggest real-world challenges in glaucoma care because the drops treat a condition you can’t feel. If side effects like redness or stinging make your drops hard to tolerate, your doctor can usually switch you to a different formulation.
Laser Treatment as a First or Second Step
Selective laser trabeculoplasty, commonly called SLT, is a quick in-office procedure that uses targeted laser pulses to improve fluid drainage in the eye. It takes a few minutes, causes minimal discomfort, and requires no recovery time. Increasingly, eye doctors offer it as a first-line treatment rather than waiting until drops fail.
When used as the initial treatment, SLT achieves target eye pressure in about 65% of patients without any medication at all over a year of follow-up. Pressure drops by roughly 40% on average. For patients already on eye drops, adding SLT allowed about 72% to reduce or stop their medications entirely, cutting the average number of daily drops from about two to fewer than one. When SLT is combined with additional treatment as needed, success rates climb above 95%.
The effect of SLT fades over time, typically lasting one to five years, but the procedure can be repeated. This makes it appealing for younger patients or anyone who struggles with daily eye drops.
Minimally Invasive Surgery for Mild to Moderate Cases
A category of procedures known as minimally invasive glaucoma surgery, or MIGS, has expanded treatment options significantly in the past decade. These involve implanting a tiny device or removing a small strip of tissue inside the eye’s natural drainage system to improve fluid outflow. They’re often performed at the same time as cataract surgery, since both require similar access to the eye.
The most common MIGS procedures either remove a section of the tissue blocking the drainage channel or insert a microscopic stent to keep the channel open. One microstent, the Hydrus, has shown slightly better medication-free pressure control than the smaller iStent in head-to-head trials, though the difference is modest. These devices work best for people with mild to moderate glaucoma who want to reduce their reliance on daily drops. They produce a moderate pressure reduction with a favorable safety profile, fewer complications than traditional surgery, and faster recovery.
Traditional Surgery for Advanced Glaucoma
When drops, laser, and MIGS aren’t enough, a procedure called trabeculectomy creates a new drainage pathway by making a small opening in the wall of the eye, covered by a flap of tissue. It’s the most powerful pressure-lowering surgery available, but it comes with more risk and a longer recovery period.
A large study following 286 eyes for an average of five years found that 55% achieved a pressure of 15 mmHg or below without any medication after the first year. By the five-year mark, that number dropped to 25%. This doesn’t mean the surgery failed for the other 75%; many still had good pressure control with the help of one or two drops. It does illustrate that glaucoma management is an ongoing process, not a one-time fix.
Another surgical option uses a tiny tube (a subconjunctival device like the XEN gel stent) placed just beneath the surface tissue of the eye to create a new drainage route. These sit between the modest pressure reduction of MIGS and the more aggressive approach of trabeculectomy.
Acute Angle-Closure Glaucoma: A Different Situation
Not all glaucoma is the slow, progressive type. Acute angle-closure glaucoma is a medical emergency where the drainage angle in the eye suddenly closes off completely, causing pressure to spike. Symptoms come on fast: severe eye pain, headache, nausea, blurred vision, and halos around lights. This requires immediate treatment, usually in an emergency room or eye clinic.
The first priority is bringing the pressure down rapidly with a combination of medications that reduce fluid production and draw fluid out of the eye. Once pressure drops enough for the iris to respond, a constricting drop is applied to pull the iris away from the drainage angle. The definitive treatment is a laser iridotomy, a procedure that creates a tiny hole in the iris to restore normal fluid flow between the chambers of the eye. If the other eye is anatomically at risk, the same procedure is performed preventively.
In patients who also have a cataract, removing the natural lens and replacing it with a thinner artificial one can serve as a long-term fix. The natural lens thickens with age and contributes to the crowding that triggers the attack, so replacing it addresses the root cause.
How Exercise Fits In
Physical activity has a measurable effect on eye pressure. Moderate-intensity aerobic exercise, like brisk walking, cycling, or swimming, produces temporary reductions in eye pressure. There’s also evidence that higher overall fitness levels may be protective against developing glaucoma in the first place, and that people with glaucoma who are more physically active experience slower visual field loss over time.
Heavy resistance training and weight-lifting temporarily raise eye pressure, particularly during straining and breath-holding. This doesn’t mean you need to avoid the gym entirely, but if you have glaucoma, it’s worth discussing your exercise routine with your eye doctor to find the right balance.
What Long-Term Management Looks Like
Living with glaucoma means regular monitoring for the rest of your life. Even after successful surgery or laser treatment, pressure can creep back up, and the optic nerve can continue to thin if changes go undetected. Most people see their eye doctor every three to six months for pressure checks and periodic visual field tests that map any changes in peripheral vision.
Treatment often evolves over time. You might start with one eye drop, add a second, try laser treatment, and eventually consider surgery as the disease progresses or your response to earlier treatments changes. The key is that effective options exist at every stage. Glaucoma is a condition you manage, not one you beat, but with consistent treatment, most people retain useful vision throughout their lives.